Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL17201599

Cc1cc(-c2cnc(C(=O)O)s2)cn[n+]1[O-].O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
GRIN1 Q05586 5/20 0.32
GRIN2B Q13224 5/20 0.32
HDAC4 P56524 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HCAR2 Q8TDS4 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GLA P06280 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ESR1 P03372 1/20 0.30
DGAT1 O75907 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201600 0.82 CTSS (0.37) CTSSCTSKHSD17B1HSD17B2GRIN1
SCHEMBL17201693 0.78 CTSS (0.39) CTSSCTSKHSD17B1HSD17B2ALDH1A1
Trifluoroacetic Acid SCHEMBL17201525 0.76 HDAC6 (0.37) CTSSCTSKHSD17B1HSD17B2HDAC4
Trifluoroacetic Acid SCHEMBL17201554 0.76 CTSS (0.36) CTSSCTSKHSD17B1HSD17B2HDAC4
Trifluoroacetic Acid SCHEMBL17201556 0.71 HDAC6 (0.37) CTSSCTSKHSD17B1HSD17B2HDAC4
Trifluoroacetic Acid SCHEMBL17201540 0.69 CDC7 (0.44) CTSSCTSKHSD17B1HSD17B2HDAC4
SCHEMBL24369189 0.67 CYP11B2 (0.41) GRIN1GRIN2BHDAC6KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL17204972 0.67 KDM4E (0.39) CTSSCTSKHDAC4HDAC6HCAR2
SCHEMBL17053175 0.66 WNT3A (0.48) CTSSCTSKHSD17B1HSD17B2
SCHEMBL12688213 0.66 HSD17B1 (0.65) HSD17B1HSD17B2HDAC6KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725459-B2 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I GRUNENTHAL GMBH (DE) 2017-08-08 US disclosed
EP-3140309-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2017-03-15 EP disclosed
WO-2015161928-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 WO disclosed
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I CTSK, OPRK1, CAT CTSS 33/4885CTSK 1/4885HSD17B1 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.